Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHOENICS: Volulyte 6% vs Ionolyte in Elective Abdominal Surgery
NCT03278548Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Sep 2017
- Primary completion
- Apr 2022
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of hetastarch in hypovolemia, sponsored by Fresenius Kabi. Started Sep 2017; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT03278548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03278548.